Table of Contents Executive Summary 1 Industry Overview of Peripheral Arterial Disease (PAD) Drugs 1.1 Definition of Peripheral Arterial Disease (PAD) Drugs 1.2 Peripheral Arterial Disease (PAD) Drugs Segment by Type 1.2.1 Global Peripheral Arterial Disease (PAD) Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Clopidogrel (Plavix) 1.2.3 Prasugrel (Effient) 1.2.4 Ticagrelor (Brilinta) 1.2.5 Vorapaxar (Zontivity) 1.2.6 Others 1.3 Peripheral Arterial Disease (PAD) Drugs Segment by Applications 1.3.1 Global Peripheral Arterial Disease (PAD) Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Global Peripheral Arterial Disease (PAD) Drugs Overall Market 1.4.1 Global Peripheral Arterial Disease (PAD) Drugs Revenue (2014-2025) 1.4.2 Global Peripheral Arterial Disease (PAD) Drugs Production (2014-2025) 1.4.3 North America Peripheral Arterial Disease (PAD) Drugs Status and Prospect (2014-2025) 1.4.4 Europe Peripheral Arterial Disease (PAD) Drugs Status and Prospect (2014-2025) 1.4.5 China Peripheral Arterial Disease (PAD) Drugs Status and Prospect (2014-2025) 1.4.6 Japan Peripheral Arterial Disease (PAD) Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Status and Prospect (2014-2025) 1.4.8 India Peripheral Arterial Disease (PAD) Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Peripheral Arterial Disease (PAD) Drugs 2.3 Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Drugs 2.4 Industry Chain Structure of Peripheral Arterial Disease (PAD) Drugs 3 Development and Manufacturing Plants Analysis of Peripheral Arterial Disease (PAD) Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Peripheral Arterial Disease (PAD) Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Peripheral Arterial Disease (PAD) Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Peripheral Arterial Disease (PAD) Drugs Production and Capacity Analysis 4.2 Peripheral Arterial Disease (PAD) Drugs Revenue Analysis 4.3 Peripheral Arterial Disease (PAD) Drugs Price Analysis 4.4 Market Concentration Degree 5 Peripheral Arterial Disease (PAD) Drugs Regional Market Analysis 5.1 Peripheral Arterial Disease (PAD) Drugs Production by Regions 5.1.1 Global Peripheral Arterial Disease (PAD) Drugs Production by Regions 5.1.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue by Regions 5.2 Peripheral Arterial Disease (PAD) Drugs Consumption by Regions 5.3 North America Peripheral Arterial Disease (PAD) Drugs Market Analysis 5.3.1 North America Peripheral Arterial Disease (PAD) Drugs Production 5.3.2 North America Peripheral Arterial Disease (PAD) Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Peripheral Arterial Disease (PAD) Drugs Import and Export 5.4 Europe Peripheral Arterial Disease (PAD) Drugs Market Analysis 5.4.1 Europe Peripheral Arterial Disease (PAD) Drugs Production 5.4.2 Europe Peripheral Arterial Disease (PAD) Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Peripheral Arterial Disease (PAD) Drugs Import and Export 5.5 China Peripheral Arterial Disease (PAD) Drugs Market Analysis 5.5.1 China Peripheral Arterial Disease (PAD) Drugs Production 5.5.2 China Peripheral Arterial Disease (PAD) Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Peripheral Arterial Disease (PAD) Drugs Import and Export 5.6 Japan Peripheral Arterial Disease (PAD) Drugs Market Analysis 5.6.1 Japan Peripheral Arterial Disease (PAD) Drugs Production 5.6.2 Japan Peripheral Arterial Disease (PAD) Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Peripheral Arterial Disease (PAD) Drugs Import and Export 5.7 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Analysis 5.7.1 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Production 5.7.2 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Import and Export 5.8 India Peripheral Arterial Disease (PAD) Drugs Market Analysis 5.8.1 India Peripheral Arterial Disease (PAD) Drugs Production 5.8.2 India Peripheral Arterial Disease (PAD) Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Peripheral Arterial Disease (PAD) Drugs Import and Export 6 Peripheral Arterial Disease (PAD) Drugs Segment Market Analysis (by Type) 6.1 Global Peripheral Arterial Disease (PAD) Drugs Production by Type 6.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue by Type 6.3 Peripheral Arterial Disease (PAD) Drugs Price by Type 7 Peripheral Arterial Disease (PAD) Drugs Segment Market Analysis (by Application) 7.1 Global Peripheral Arterial Disease (PAD) Drugs Consumption by Application 7.2 Global Peripheral Arterial Disease (PAD) Drugs Consumption Market Share by Application (2014-2019) 8 Peripheral Arterial Disease (PAD) Drugs Major Manufacturers Analysis 8.1 AstraZeneca Plc. (UK) 8.1.1 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served 8.1.2 AstraZeneca Plc. (UK) Product Introduction, Application and Specification 8.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Bayer HealthCare Pharmaceuticals (Germany) 8.2.1 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served 8.2.2 Bayer HealthCare Pharmaceuticals (Germany) Product Introduction, Application and Specification 8.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Bristol-Myers Squibb Company (US) 8.3.1 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served 8.3.2 Bristol-Myers Squibb Company (US) Product Introduction, Application and Specification 8.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Merck & Co., Inc. (US) 8.4.1 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served 8.4.2 Merck & Co., Inc. (US) Product Introduction, Application and Specification 8.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Proteon Therapeutics, Inc. (US) 8.5.1 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served 8.5.2 Proteon Therapeutics, Inc. (US) Product Introduction, Application and Specification 8.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Sanofi S.A. (France) 8.6.1 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served 8.6.2 Sanofi S.A. (France) Product Introduction, Application and Specification 8.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Symic Bio, Inc. (US) 8.7.1 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served 8.7.2 Symic Bio, Inc. (US) Product Introduction, Application and Specification 8.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 TheraVasc Inc. (US) 8.8.1 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served 8.8.2 TheraVasc Inc. (US) Product Introduction, Application and Specification 8.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 9 Development Trend of Analysis of Peripheral Arterial Disease (PAD) Drugs Market 9.1 Global Peripheral Arterial Disease (PAD) Drugs Market Trend Analysis 9.1.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Peripheral Arterial Disease (PAD) Drugs Regional Market Trend 9.2.1 North America Peripheral Arterial Disease (PAD) Drugs Forecast 2019-2025 9.2.2 Europe Peripheral Arterial Disease (PAD) Drugs Forecast 2019-2025 9.2.3 China Peripheral Arterial Disease (PAD) Drugs Forecast 2019-2025 9.2.4 Japan Peripheral Arterial Disease (PAD) Drugs Forecast 2019-2025 9.2.5 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Forecast 2019-2025 9.2.6 India Peripheral Arterial Disease (PAD) Drugs Forecast 2019-2025 9.3 Peripheral Arterial Disease (PAD) Drugs Market Trend (Product Type) 9.4 Peripheral Arterial Disease (PAD) Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Peripheral Arterial Disease (PAD) Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Peripheral Arterial Disease (PAD) Drugs Table Global Peripheral Arterial Disease (PAD) Drugs Production (Units) Growth Rate Comparison by Types (2014-2025) Figure Global Peripheral Arterial Disease (PAD) Drugs Production Market Share by Types in 2018 Figure Clopidogrel (Plavix) Product Picture Figure Prasugrel (Effient) Product Picture Figure Ticagrelor (Brilinta) Product Picture Figure Vorapaxar (Zontivity) Product Picture Figure Others Product Picture Table Global Peripheral Arterial Disease (PAD) Drugs Consumption (Units) Comparison by Applications (2014-2025) Figure Global Peripheral Arterial Disease (PAD) Drugs Consumption Market Share by Applications in 2018 Figure Hospitals Figure Clinics Figure Others Figure Global Peripheral Arterial Disease (PAD) Drugs Revenue (Million USD) (2014-2025) Figure Global Peripheral Arterial Disease (PAD) Drugs Production (Units) (2014-2025) Figure North America Peripheral Arterial Disease (PAD) Drugs Market Size (Million USD) (2014-2025) Figure Europe Peripheral Arterial Disease (PAD) Drugs Market Size (Million USD) (2014-2025) Figure China Peripheral Arterial Disease (PAD) Drugs Market Size (Million USD) (2014-2025) Figure Japan Peripheral Arterial Disease (PAD) Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size (Million USD) (2014-2025) Figure India Peripheral Arterial Disease (PAD) Drugs Market Size (Million USD) (2014-2025) Table Peripheral Arterial Disease (PAD) Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Peripheral Arterial Disease (PAD) Drugs in 2018 Figure Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Drugs Figure Industry Chain Structure of Peripheral Arterial Disease (PAD) Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Peripheral Arterial Disease (PAD) Drugs Manufacturing Plants Distribution Table Peripheral Arterial Disease (PAD) Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Peripheral Arterial Disease (PAD) Drugs Capacity (Units) of Major Manufacturers (2014-2019) Table Peripheral Arterial Disease (PAD) Drugs Production (Units) of Major Manufacturers (2014-2019) Table Peripheral Arterial Disease (PAD) Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Peripheral Arterial Disease (PAD) Drugs Production Share by Manufacturers in 2018 Table Peripheral Arterial Disease (PAD) Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Peripheral Arterial Disease (PAD) Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Peripheral Arterial Disease (PAD) Drugs Revenue Share by Manufacturers in 2018 Table Peripheral Arterial Disease (PAD) Drugs Average Price (K USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Peripheral Arterial Disease (PAD) Drugs Production by Regions 2014-2019 (Units) Table Global Peripheral Arterial Disease (PAD) Drugs Production Market Share by Regions 2014-2019 Figure Global Peripheral Arterial Disease (PAD) Drugs Production Market Share by Regions in 2018 Table Global Peripheral Arterial Disease (PAD) Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Regions 2014-2019 Figure Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Regions in 2018 Table Global Peripheral Arterial Disease (PAD) Drugs Consumption by Regions 2014-2019 (Units) Table Global Peripheral Arterial Disease (PAD) Drugs Consumption Market Share by Regions 2014-2019 Figure North America Peripheral Arterial Disease (PAD) Drugs Production Growth Rate 2014-2019 (Units) Figure North America Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Peripheral Arterial Disease (PAD) Drugs Production, Consumption Import and Export (Units) Figure Europe Peripheral Arterial Disease (PAD) Drugs Production Growth Rate 2014-2019 (Units) Figure Europe Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Peripheral Arterial Disease (PAD) Drugs Production, Consumption Import and Export (Units) Figure China Peripheral Arterial Disease (PAD) Drugs Production Growth Rate 2014-2019 (Units) Figure China Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Peripheral Arterial Disease (PAD) Drugs Production, Consumption Import and Export (Units) Figure Japan Peripheral Arterial Disease (PAD) Drugs Production Growth Rate 2014-2019 (Units) Figure Japan Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Peripheral Arterial Disease (PAD) Drugs Production, Consumption Import and Export (Units) Figure Southeast Asia Peripheral Arterial Disease (PAD) Drugs Production Growth Rate 2014-2019 (Units) Figure Southeast Asia Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Peripheral Arterial Disease (PAD) Drugs Production, Consumption Import and Export (Units) Figure India Peripheral Arterial Disease (PAD) Drugs Production Growth Rate 2014-2019 (Units) Figure India Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Peripheral Arterial Disease (PAD) Drugs Production, Consumption Import and Export (Units) Figure Global Consumption Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2014-2019) Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Product Introduction, Application and Specification Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Production Growth Rate (2014-2019) Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Production Market Share (2014-2019) Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Revenue Market Share (2014-2019) Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Main Business and Markets Served Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product Introduction, Application and Specification Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019) Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Production Growth Rate (2014-2019) Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Production Market Share (2014-2019) Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue Market Share (2014-2019) Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Main Business and Markets Served Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product Introduction, Application and Specification Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019) Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Production Growth Rate (2014-2019) Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Production Market Share (2014-2019) Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue Market Share (2014-2019) Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Main Business and Markets Served Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product Introduction, Application and Specification Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019) Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Growth Rate (2014-2019) Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Market Share (2014-2019) Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Revenue Market Share (2014-2019) Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Main Business and Markets Served Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product Introduction, Application and Specification Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019) Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Growth Rate (2014-2019) Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Market Share (2014-2019) Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Revenue Market Share (2014-2019) Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Main Business and Markets Served Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Product Introduction, Application and Specification Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019) Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Production Growth Rate (2014-2019) Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Production Market Share (2014-2019) Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Revenue Market Share (2014-2019) Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Main Business and Markets Served Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product Introduction, Application and Specification Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019) Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Growth Rate (2014-2019) Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Market Share (2014-2019) Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Revenue Market Share (2014-2019) Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Main Business and Markets Served Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Sites and Area Served Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product Introduction, Application and Specification Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019) Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Growth Rate (2014-2019) Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Market Share (2014-2019) Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Revenue Market Share (2014-2019) Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Main Business and Markets Served Figure Global Peripheral Arterial Disease (PAD) Drugs Production (Units) Growth Rate Forecast 2019-2025 Figure Global Peripheral Arterial Disease (PAD) Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Price (K USD/Unit) Forecast 2019-2025 Figure North America Peripheral Arterial Disease (PAD) Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure North America Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Peripheral Arterial Disease (PAD) Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure Europe Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Peripheral Arterial Disease (PAD) Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure China Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Peripheral Arterial Disease (PAD) Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure Japan Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Peripheral Arterial Disease (PAD) Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure Southeast Asia Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Peripheral Arterial Disease (PAD) Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure India Peripheral Arterial Disease (PAD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (Units) of Peripheral Arterial Disease (PAD) Drugs by Type (2019-2025) Table Global Consumption (Units) of Peripheral Arterial Disease (PAD) Drugs by Application (2019-2025) Table Peripheral Arterial Disease (PAD) Drugs Distributors List Table Peripheral Arterial Disease (PAD) Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Plc. (UK) Bayer HealthCare Pharmaceuticals (Germany) Bristol-Myers Squibb Company (US) Merck & Co., Inc. (US) Proteon Therapeutics, Inc. (US) Sanofi S.A. (France) Symic Bio, Inc. (US) TheraVasc Inc. (US)